Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2022

Open Access 01-12-2022 | Study protocol

Group psychoeducation for persons with bipolar disorder in Rwanda: a study protocol for a randomized controlled trial

Authors: E. Musoni-Rwililiza, C. J. Arnbjerg, C. Murekatete, J. Carlsson, P. Kallestrup, D. Gishoma

Published in: Trials | Issue 1/2022

Login to get access

Abstract

Background

The efficacy of psychoeducation as an add-on treatment to pharmacotherapy is well documented in treating symptoms and in relapse prevention for persons with bipolar disorder in western countries. Yet, no studies on psychosocial interventions for persons with bipolar disorder have been conducted in a low-income country in Africa.

Aim

To develop a bipolar group psychoeducation program contextualized to the Rwandese setting, and determine its effect on symptom severity, medical adherence, and internalized stigma.

Methods

A culturally adapted guide manual was developed by local mental health professionals, including nurses, psychologists, and medical doctors. In-depth interviews with participants were held prior to and will be held following the intervention to address the cultural aspect of living with bipolar disease and the impact of the program. A two-armed randomized controlled trial has been set up at the tertiary mental health hospitals in Rwanda, with an intervention and a waiting list arm. A sample size of at least 50 in each arm was calculated as a requirement. The study’s primary outcome measure will be the difference in relapse rate measured on the Young Mania Rating Scale and Hamilton Depression Scale-17. Differences in mean change on scales for medical adherence and internalized stigma will be secondary outcomes. Data will be analyzed according to the intention-to-treat principle. Participants will be assessed subsequently at baseline, at the end of the intervention period, and three months and 12 months post-intervention.

Discussion

This study will be one of the first intervention trials on bipolar disorder in a low-income country. If proven successful in reducing morbidity and increasing the quality of life in persons with bipolar disorder, it is anticipated that the psychoeducation program can be implemented at the district and community level and act as inspiration for other low-resource settings.

Trial registration

ClinicalTrials.gov NCT04671225. Registered on November 2020.
Literature
1.
Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry. 2016;3:171–8 Elsevier Ltd.CrossRefPubMed
2.
Whiteford HA, Ferrari AJ, Degenhardt L, Feigin V, Vos T. The global burden of mental, neurological and substance use disorders: An analysis from the global burden of disease study 2010. PLoS One. 2015;10(2).
3.
4.
Gilbert BJ, Patel V, Farmer PE, Lu C. Assessing Development Assistance for Mental Health in Developing Countries : 2007 – 2013. PLoS Med. 2015;12(6). San Francisco.
5.
Rathod S, Pinninti N, Irfan M, Gorczynski P, Rathod P, Gega L, et al. Mental Health Service Provision in Low- and Middle-Income Countries. Heal Serv Insights. 2017;10.
6.
Mackenzie J, Kesner C. Mental health funding and the SDGs What now and who pays? UK’s Overseas Dev Inst. 2016;(May).
7.
Kleinman A. The art of medicine Global mental health : a failure of humanity. Lancet. 2009;374(9690):603–4.CrossRefPubMed
8.
Liu NH, Daumit GL, Dua T, Aquila R, Charlson F, Cuijpers P, et al. Excess mortality in persons with severe mental disorders : a multilevel intervention framework and priorities for clinical practice , policy and research agendas. World Psychiatry. 2017;(February):30–40.
9.
Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. Bull World Health Organ. 2004;82(11):858–66.PubMedPubMedCentral
10.
11.
Burns JK, Tomita A. Traditional and religious healers in the pathway to care for people with mental disorders in Africa: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2015;50(6):867–77.CrossRefPubMed
12.
Keynejad RC, Dua T, Barbui C, Thornicroft G. WHO Mental Health Gap Action Programme (mhGAP) Intervention Guide: A systematic review of evidence from low and middleincome countries. Evid Based Ment Health. 2018;21(1):29–33.CrossRef
13.
14.
World Health Assembly, 69. Framework on integrated , people - centred health services. Report by the Secretariat: World Health Organization; 2016.
15.
Mohand AA, Kayiteshonga Y, Misago NC, D’Arc Dusabeyezu JDL J. Decentralization and integration of mental health care into primary health care: A case study of Rwanda: Ministry of Health; 2017. p. 55–66.
16.
17.
Colom F. The evolution of psychoeducation for bipolar disorder : from lithium clinics to integrative psychoeducation. World Psychiatry. 2014;3:90–2.CrossRef
18.
SA S. Randomized Controlled Trials of Psychoeducation Modalities in the Management of Bipolar Disorder: A Systematic Review. J Clin Psychiatry. 2018;79(3).
19.
Demissie M, Hanlon C, Birhane R, Ng L, Medhin G, Fekadu A. Psychological interventions for bipolar disorder in low- and middle-income countries: systematic review. BJPsych Open. 2018;4(5):375–84.CrossRefPubMedPubMedCentral
20.
Bauer MML. The life goals program: Structured group psychotherapy for bipolar disorder. 1996.
21.
Chan A, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. Research methods and reporting spirit 2013 explanation and elaboration : guidance for protocols of clinical trials. BMJ. 2013:1–42.
22.
Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, et al. Long-term impact of the life goals group therapy program for bipolar patients. J Affect Disord. 2012;136(3):889–94.CrossRef
23.
Sheehan DV, Lecrubier Y, Sheehan KH, Pam D, et al. The Mini-International The Development and Validation of a Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10. 1998;59(suppl 20).
24.
Weathers FW, Blake DD, Schnurr PP, Kaloupek DG, Marx BP, Keane TM. The Life Events Checklist for DSM-5 (LEC-5) – Standard. [Measurement instrument]. 2013. Available from https://​www.​ptsd.​va.​gov/​.
25.
Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults. Am J Psychiatry. 2011;168(12):1266–77.CrossRefPubMedPubMedCentral
26.
Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry. 1978;133(11):429–35.CrossRefPubMed
27.
Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278–96.CrossRefPubMed
28.
Spearing MK, Post RM, Levericha GS, Brandtb D, Nolenc W. Modification of the Clinical Global Impressions (GCI) scale for use in bipolar illness (BP): the GCI-BP. Psychiatry Res. 1997;73:1–13. Available from: papers://9813c380-4a5a-426e-ab3b-10e227534cf8/Paper/p600.
29.
Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42(3):241–7.CrossRefPubMed
30.
Hammer JH, Toland MD. Internal structure and reliability of the Internalized Stigma of Mental Illness Scale (ISMI-29) and Brief Versions (ISMI-10, ISMI-9) among Americans with depression. Stigma Heal. 2017;2(3):159–74.CrossRef
31.
Colom F, Vieta E, Martínez-Arán A, Reinares M, Goikolea JM, Benabarre A, et al. A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission. Arch Gen Psychiatry. 2003;60(4):402.CrossRefPubMed
Metadata
Title
Group psychoeducation for persons with bipolar disorder in Rwanda: a study protocol for a randomized controlled trial
Authors
E. Musoni-Rwililiza
C. J. Arnbjerg
C. Murekatete
J. Carlsson
P. Kallestrup
D. Gishoma
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06926-1

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue

Research

Evaluation of cultural competency in a South African cluster randomised controlled trial: lessons learned for trial reporting standards

Study protocol

Animated, video entertainment-education to improve vaccine confidence globally during the COVID-19 pandemic: an online randomized controlled experiment with 24,000 participants

Research

A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury

Study protocol

Efficacy of dexmedetomidine on postoperative pain in patients undergoing gastric and esophageal endoscopic submucosal dissection: a study protocol for a randomized controlled prospective trial

Research

Access to unpublished protocols and statistical analysis plans of randomised trials

Commentary

Postpartum haemorrhage in anaemic women: assessing outcome measures for clinical trials